EPISODE · Aug 19, 2026 · 19 MIN
アミリックス株が63.8%急騰 「反GLP-1」新薬avexitideが変える成長シナリオ
from 米国株投資で幸せ作り · host beikoku-stock
「反GLP-1」新薬avexitideで注目を集めるアミリックス(AMLX)。第3相試験成功、株価63.8%急騰の背景と、研究開発企業から商業化企業への成長可能性を分析します。https://beikoku-stock.com/2026/08/19/amylyx-avexitide-glp1-stock-surge/
Embed this episode
Ready to play
アミリックス株が63.8%急騰 「反GLP-1」新薬avexitideが変える成長シナリオ
0:00
19:10
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 米国株投資で幸せ作り?
This episode is 19 minutes long.
When was this 米国株投資で幸せ作り episode published?
This episode was published on August 19, 2026.
Can I download this 米国株投資で幸せ作り episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!